sq-11725 has been researched along with Hypertension, Portal in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (24.00) | 18.7374 |
| 1990's | 7 (28.00) | 18.2507 |
| 2000's | 11 (44.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Urturi, C; Aracil, C; Balanzó, J; Colomo, A; Guarner, C; Hernández-Gea, V; López-Balaguer, JM; Torras, X; Villanueva, C | 1 |
| Chen, WC; Lo, GH; Wang, HM; Yu, HC | 1 |
| Aracil, C; Balanzó, J; González, B; Guarner, C; Kolle, L; López-Balaguer, JM; Miñana, J; Soriano, G; Villanueva, C | 1 |
| Mann, NS | 1 |
| Bolognesi, M; Bombonato, G; Cavasin, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
| Bosch, J | 2 |
| Andreone, P; Berzigotti, A; Magalotti, D; Morelli, MC; Rinaldi, MF; Rossi, C; Zappoli, P; Zoli, M | 1 |
| Balanzo, J; Cusso, X; Gallego, A; Gonzalez-Suarez, B; Guarner, C; Minana, J; Sainz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
| Laleman, W; Nevens, F | 1 |
| Battaglia, G; Gatta, A; Merkel, C; Milani, L; Sacerdoti, D; Zuin, R | 1 |
| Bellon, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
| Bolognesi, M; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
| Cho, CH; Yat, PC | 1 |
| Angeli, P; Bolognesi, M; Bombonato, G; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sacerdoti, D | 1 |
| Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
| Amodio, P; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Mazzaro, C; Merkel, C; Sacerdoti, D; Sebastianelli, G; Torboli, P | 1 |
| Bellini, B; Bighin, R; Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
| Crespi, C; De Giorgio, AM | 1 |
| Gatta, A; Merkel, C; Sacerdoti, D | 1 |
| Ohara, N; Reichen, J | 1 |
| Angeli, P; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Ruol, A; Sacerdoti, D; Zuin, R | 1 |
| Angeli, P; Bolognesi, M; Finucci, GF; Gatta, A; Merkel, C; Ruol, A; Sacerdoti, D | 1 |
| Bazzerla, G; Bolognesi, M; Finucci, GF; Gatta, A; Merkel, C; Sacerdoti, D; Zuin, R | 1 |
| Bolognesi, M; Finucci, G; Gatta, A; Merkel, C; Rossoni, R; Sacerdoti, D; Zuin, R | 1 |
3 review(s) available for sq-11725 and Hypertension, Portal
| Article | Year |
|---|---|
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents | 2006 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Pharmacological therapy of portal hypertension.
Topics: Acute Disease; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hypertension, Portal; Nadolol; Propranolol; Somatostatin; Vasopressins | 1986 |
11 trial(s) available for sq-11725 and Hypertension, Portal
| Article | Year |
|---|---|
Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Portal Pressure; Predictive Value of Tests; Proportional Hazards Models; Propranolol; Risk Assessment; ROC Curve; Time Factors; Treatment Outcome | 2009 |
Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Chi-Square Distribution; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Propanolamines; Proportional Hazards Models; Secondary Prevention; Vasodilator Agents | 2012 |
Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Ascites; Esophageal and Gastric Varices; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nadolol; Prognosis | 2004 |
Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis?
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Biopsy; Disease Progression; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Follow-Up Studies; Humans; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Nadolol; Single-Blind Method; Treatment Outcome | 2005 |
Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis.
Topics: Adrenergic beta-Antagonists; Bacterial Infections; Community-Acquired Infections; Drug Therapy, Combination; Epidemiologic Methods; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Peritonitis; Sclerotherapy; Secondary Prevention; Vasodilator Agents | 2006 |
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Topics: Administration, Oral; Adult; Aged; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Liver; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged; Nadolol; Pulsatile Flow; Splanchnic Circulation; Ultrasonography, Doppler, Color; Vascular Resistance; Vasodilator Agents | 1995 |
Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Topics: Adult; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Renal Circulation; Splanchnic Circulation; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1994 |
Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Hepatic Artery; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Nadolol; Vasodilator Agents | 1997 |
Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
Topics: Adrenergic beta-Antagonists; Catheterization, Peripheral; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Linear Models; Liver Cirrhosis; Male; Middle Aged; Nadolol; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1998 |
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Randomized Controlled Trials as Topic | 2000 |
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial.
Topics: Adult; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nadolol; Random Allocation; Recurrence | 1987 |
11 other study(ies) available for sq-11725 and Hypertension, Portal
| Article | Year |
|---|---|
Nadolol versus band ligation for prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Chronotherapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Nadolol; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
Topics: Acute Disease; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Chronic Disease; Female; Heart Rate; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nadolol; Treatment Outcome | 2005 |
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders.
Topics: Adrenergic beta-Antagonists; Blood Flow Velocity; Disease Progression; Female; Follow-Up Studies; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Mesenteric Arteries; Middle Aged; Nadolol; Primary Prevention; Prospective Studies; Splanchnic Circulation; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasoconstriction | 2006 |
Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Diuresis; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Nadolol; Propanolamines; Renal Circulation | 1984 |
Effects of beta-adrenoceptor antagonists on portal vein hypertension and ethanol-induced gastric mucosal damage in rats.
Topics: Adrenergic beta-Antagonists; Animals; Ethanol; Gastric Mucosa; Hemodynamics; Hypertension, Portal; Labetalol; Male; Metoprolol; Nadolol; Pindolol; Propranolol; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1994 |
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents | 2000 |
[Association of biliary calculosis and portal cavernomatosis].
Topics: Cholangiography; Cholelithiasis; Famotidine; Female; Follow-Up Studies; Hemangioma, Cavernous; Humans; Hypertension, Portal; Middle Aged; Nadolol; Portal Vein; Thrombosis; Time Factors | 1992 |
Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis.
Topics: Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Male; Nadolol; Time Factors | 1991 |
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics.
Topics: Adult; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Renal Circulation | 1987 |
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.
Topics: Adult; Antihypertensive Agents; Hepatic Veins; Humans; Hypertension, Portal; Liver; Liver Circulation; Liver Cirrhosis; Middle Aged; Nadolol; Propanolamines; Venous Pressure | 1986 |
Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
Topics: Cardiac Output; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Nadolol; Propanolamines | 1985 |